Applied DNA Sciences (NASDAQ:APDN) Trading Down 26.8%

Applied DNA Sciences Inc (NASDAQ:APDN) shares traded down 26.8% during mid-day trading on Thursday . The company traded as low as $0.29 and last traded at $0.30, 2,177,495 shares were traded during trading. An increase of 332% from the average session volume of 504,026 shares. The stock had previously closed at $0.41.

Separately, Maxim Group reissued a “hold” rating on shares of Applied DNA Sciences in a research note on Wednesday, June 12th.

The company has a debt-to-equity ratio of 2.82, a quick ratio of 0.66 and a current ratio of 0.81. The stock’s 50 day moving average price is $0.30 and its 200-day moving average price is $0.50.



Applied DNA Sciences (NASDAQ:APDN) last issued its earnings results on Tuesday, August 13th. The technology company reported ($0.04) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.06) by $0.02. The firm had revenue of $2.05 million during the quarter. Applied DNA Sciences had a negative net margin of 221.66% and a negative return on equity of 1,284.19%.

In related news, major shareholder William W. Montgomery bought 400,000 shares of the stock in a transaction dated Thursday, August 22nd. The stock was purchased at an average cost of $0.27 per share, with a total value of $108,000.00. Following the completion of the purchase, the insider now owns 5,630,900 shares of the company’s stock, valued at $1,520,343. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 20.46% of the stock is currently owned by insiders.

Large investors have recently added to or reduced their stakes in the stock. Capital Investment Advisors LLC purchased a new stake in Applied DNA Sciences in the second quarter worth about $27,000. Wells Fargo & Company MN purchased a new stake in Applied DNA Sciences in the second quarter worth about $54,000. Finally, Laurel Wealth Advisors Inc. purchased a new stake in Applied DNA Sciences in the first quarter worth about $71,000. 5.04% of the stock is owned by institutional investors.

About Applied DNA Sciences (NASDAQ:APDN)

Applied DNA Sciences, Inc develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA.

Recommended Story: What is Depreciation?

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.